Merit Financial Group, LLC Immunity Bio, Inc. Transaction History
Merit Financial Group, LLC
- $6.49 Billion
- Q1 2025
A detailed history of Merit Financial Group, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 44,244 shares of IBRX stock, worth $138,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
44,244
Previous 43,809
0.99%
Holding current value
$138,926
Previous $112,000
23.21%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IBRX
# of Institutions
230Shares Held
82.3MCall Options Held
1.02MPut Options Held
2.25M-
Vanguard Group Inc Valley Forge, PA17.3MShares$54.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$35.9 Million0.0% of portfolio
-
State Street Corp Boston, MA9.79MShares$30.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$12.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.84MShares$12.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.26B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...